Drug abuse by an individual during adolescence, a significant period of maturation, may enhance their vulnerability to the central nervous system (CNS) effects of abused drugs. The present application brings together a multidisciplinary team of investigators to examine whether pharmacodynamic changes resulting from the presence of ovarian hormones and chronic A9-THC administration alters the subjective effects of the drug, increases the vulnerability of females to drug abuse, and changes their ability to learn. Chronic exposure to A9-THC is of particular interest because this illicit drug is widely abused by adolescents, while the presence or absence of ovarian hormones is of interest as a cofactor because: 1) ovarian hormones may have independent or interactive influences on maturation and 2) published data generated by these investigators indicate that the ovarian hormone estrogen can attenuate the detrimental effects of A9- THC on learning in female rats and alter the binding of cannabinoid ligands in brain areas that are critical for learning such as the hippocampus. For these same reasons, and because there is a paucity of data regarding the effects of A9- THC using female models, all of the planned behavioral experiments will use female rats and involve the presence or absence of ovarian hormones in A9-THC-treated subjects. In addition, subjects in each behavioral group will be sacrificed to examine potential changes in cannabinoid receptors and endogenous cannabinoid levels in relevant brain areas. More specifically, the aims of this grant will determine whether: 1) peri-adolescent A9-THC administration in gonadally intact female rats will alter their sensitivity as adults to the acute behavioral effects of A9-THC when compared to either gonadally intact or ovariectomized females that were drug-naive during adolescence; 2) peri-adolescent A9- THC administration in gonadally intact female rats will alter the pharmacodynamic response of the cannabinoid system to acute challenge with A9-THC as an adult when compared to either gonadally intact or ovariectomized females that were drug-naive during adolescence; 3) A9-THC administration from adolescence to adulthood in gonadally intact female rats will produce effects on learning that are different from those produced in either gonadally intact or ovariectomized females whose chronic administration of A9-THC did not start until post adolescence; and 4) A9-THC administration from adolescence to adulthood in gonadally intact female rats will alter the endogenous response of the cannabinoid system when compared to either gonadally intact or ovariectomized females whose chronic administration of A9-THC did not start until post adolescence. Together, data from these experiments will demonstrate how drug abuse and hormonal status during adolescence may permanently alter brain function and the liability of subsequent abuse of A9-THC. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA019625-02
Application #
7198106
Study Section
Developmental Brain Disorders Study Section (DBD)
Program Officer
Purohit, Vishnudutt
Project Start
2006-03-15
Project End
2011-02-28
Budget Start
2007-03-01
Budget End
2008-02-29
Support Year
2
Fiscal Year
2007
Total Cost
$242,204
Indirect Cost
Name
Louisiana State Univ Hsc New Orleans
Department
Pharmacology
Type
Schools of Medicine
DUNS #
782627814
City
New Orleans
State
LA
Country
United States
Zip Code
70112
Winsauer, Peter J; Sutton, Jessie L (2014) Chronic administration during early adulthood does not alter the hormonally-dependent disruptive effects of delta-9-tetrahydrocannabinol (?9-THC) on complex behavior in female rats. Pharmacol Biochem Behav 117:118-27
Winsauer, Peter J; Filipeanu, Catalin M; Bailey, Evangeline M et al. (2012) Ovarian hormones and chronic administration during adolescence modify the discriminative stimulus effects of delta-9-tetrahydrocannabinol (??-THC) in adult female rats. Pharmacol Biochem Behav 102:442-9
Amato, Russell J; Moerschbaecher, Joseph M; Winsauer, Peter J (2011) Effects of pregnanolone and flunitrazepam on the retention of response sequences in rats. Pharmacol Biochem Behav 99:391-8
Filipeanu, Catalin M; Guidry, Jesse J; Leonard, Stuart T et al. (2011) ?9-THC increases endogenous AHA1 expression in rat cerebellum and may modulate CB1 receptor function during chronic use. J Neurochem 118:1101-12
Winsauer, Peter J; Molina, Patricia E; Amedee, Angela M et al. (2011) Tolerance to chronic delta-9-tetrahydrocannabinol (ýýýýý-THC) in rhesus macaques infected with simian immunodeficiency virus. Exp Clin Psychopharmacol 19:154-72
Winsauer, Peter J; Daniel, Jill M; Filipeanu, Catalin M et al. (2011) Long-term behavioral and pharmacodynamic effects of delta-9-tetrahydrocannabinol in female rats depend on ovarian hormone status. Addict Biol 16:64-81
Leonard, Stuart T; Hearn, John K; Catling, Andrew D et al. (2010) Gonadal hormones modulate the potency of the disruptive effects of donepezil in male rats responding under a nonspatial operant learning and performance task. Behav Pharmacol 21:121-34
Amato, Russell J; Lewis, Peter B; He, Hongbo et al. (2010) Effects of positive and negative modulators of the ?-aminobutyric acid A receptor complex on responding under a differential-reinforcement-of-low-rate schedule of reinforcement in rats. Behav Pharmacol 21:727-35
Leonard, Stuart T; Gerak, Lisa R; Delatte, Marcus S et al. (2009) Relative potency and effectiveness of flunitrazepam, ethanol, and beta-CCE for disrupting the acquisition and retention of response sequences in rats. Behav Pharmacol 20:33-44
Leonard, Stuart T; Moerschbaecher, Joseph M; Winsauer, Peter J (2008) Estradiol replacement in gonadectomized male rats alters scopolamine-induced disruptions of nonspatial learning. Exp Clin Psychopharmacol 16:532-46